201 related articles for article (PubMed ID: 29371252)
1. Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase-Associated Neurodegeneration.
Lee JH; Gregory A; Hogarth P; Rogers C; Hayflick SJ
AJNR Am J Neuroradiol; 2018 Mar; 39(3):583-588. PubMed ID: 29371252
[TBL] [Abstract][Full Text] [Related]
2. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging, susceptibility weighted imaging and quantitative susceptibility mapping findings of pantothenate kinase-associated neurodegeneration.
Zeng J; Xing W; Liao W; Wang X
J Clin Neurosci; 2019 Jan; 59():20-28. PubMed ID: 30392836
[TBL] [Abstract][Full Text] [Related]
4. Transcranial sonography in pantothenate kinase-associated neurodegeneration.
Kostić VS; Svetel M; Mijajlović M; Pavlović A; Ječmenica-Lukić M; Kozić D
J Neurol; 2012 May; 259(5):959-64. PubMed ID: 22057405
[TBL] [Abstract][Full Text] [Related]
5. Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* time.
Fermin-Delgado R; Roa-Sanchez P; Speckter H; Perez-Then E; Rivera-Mejia D; Foerster B; Stoeter P
Clin Neuroradiol; 2013 Mar; 23(1):11-5. PubMed ID: 22258188
[TBL] [Abstract][Full Text] [Related]
6. Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging.
Su D; Zhang Z; Zhang Z; Zheng S; Yao T; Dong Y; Zhu W; Wei N; Suo Y; Liu X; Zhao H; Wang Z; Ma H; Li W; Zhou J; Lam JST; Wu T; Dusek P; Stoessl AJ; Wang X; Jing J; Feng T
Neurology; 2024 Jun; 102(12):e209478. PubMed ID: 38830145
[TBL] [Abstract][Full Text] [Related]
7. Clinical, imaging and genetic profile of twenty-four patients with pantothenate kinase-associated neurodegeneration (PKAN)- A single centre study from India.
Sriram N; Holla VV; Kumari R; Kamble N; Saini J; Mahale R; Netravathi M; Padmanabha H; Gowda VK; Battu R; Pandey A; Yadav R; Muthusamy B; Pal PK
Parkinsonism Relat Disord; 2023 Jun; 111():105409. PubMed ID: 37121191
[TBL] [Abstract][Full Text] [Related]
8. Novel PANK2 mutation discovered among South East Asian children living in Thailand affected with pantothenate kinase associated neurodegeneration.
Sakpichaisakul K; Saengow VE; Suwanpratheep P; Rongnoparat K; Panthan B; Trachoo O
J Clin Neurosci; 2019 Aug; 66():187-190. PubMed ID: 31088771
[TBL] [Abstract][Full Text] [Related]
9. The "eye-of-the-tiger" sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration.
Chiapparini L; Savoiardo M; D'Arrigo S; Reale C; Zorzi G; Zibordi F; Cordelli DM; Franzoni E; Garavaglia B; Nardocci N
Neuropediatrics; 2011 Aug; 42(4):159-62. PubMed ID: 21877312
[TBL] [Abstract][Full Text] [Related]
10. Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without 'eye-of-the-tiger' sign on MRI in a pair of siblings.
Zolkipli Z; Dahmoush H; Saunders DE; Chong WK; Surtees R
Pediatr Radiol; 2006 Aug; 36(8):884-6. PubMed ID: 16758184
[TBL] [Abstract][Full Text] [Related]
11. "Eye of tiger sign" mimic in an adolescent boy with mitochondrial membrane protein associated neurodegeneration (MPAN).
Yoganathan S; Sudhakar SV; Thomas M; Dutta AK; Danda S
Brain Dev; 2016 May; 38(5):516-9. PubMed ID: 26602591
[TBL] [Abstract][Full Text] [Related]
12. Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN).
Delgado RF; Sanchez PR; Speckter H; Then EP; Jimenez R; Oviedo J; Dellani PR; Foerster B; Stoeter P
J Magn Reson Imaging; 2012 Apr; 35(4):788-94. PubMed ID: 22127788
[TBL] [Abstract][Full Text] [Related]
13. Diffusion tensor MR imaging in children with pantothenate kinase-associated neurodegeneration with brain iron accumulation and their siblings.
Awasthi R; Gupta RK; Trivedi R; Singh JK; Paliwal VK; Rathore RK
AJNR Am J Neuroradiol; 2010 Mar; 31(3):442-7. PubMed ID: 19850762
[TBL] [Abstract][Full Text] [Related]
14. [The role of magnetic resonance imaging in the diagnosis of Hallervorden-Spatz disease].
Tabuchi M; Mori E; Yamadori A
Rinsho Shinkeigaku; 1990 Sep; 30(9):972-7. PubMed ID: 2265508
[TBL] [Abstract][Full Text] [Related]
15. Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation.
Rossi D; De Grandis E; Barzaghi C; Mascaretti M; Garavaglia B; Zanotto E; Morana G; Biancheri R
Brain Dev; 2012 Jun; 34(6):536-8. PubMed ID: 21999968
[TBL] [Abstract][Full Text] [Related]
16. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.
McNeill A; Birchall D; Hayflick SJ; Gregory A; Schenk JF; Zimmerman EA; Shang H; Miyajima H; Chinnery PF
Neurology; 2008 Apr; 70(18):1614-9. PubMed ID: 18443312
[TBL] [Abstract][Full Text] [Related]
17. Pantothenate kinase 2 mutation with eye-of-the-tiger sign on magnetic resonance imaging in three siblings.
Dezfouli MA; Jaberi E; Alavi A; Rezvani M; Shahidi G; Elahi E; Rohani M
Iran J Neurol; 2012; 11(4):155-8. PubMed ID: 24250886
[TBL] [Abstract][Full Text] [Related]
18. Expanding the Spectrum of Early Neuroradiologic Findings in β Propeller Protein-Associated Neurodegeneration.
Papandreou A; Soo AKS; Spaull R; Mankad K; Kurian MA; Sudhakar S
AJNR Am J Neuroradiol; 2022 Dec; 43(12):1810-1814. PubMed ID: 36328404
[TBL] [Abstract][Full Text] [Related]
19. Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings.
Sener RN
AJNR Am J Neuroradiol; 2003 Sep; 24(8):1690-3. PubMed ID: 13679293
[TBL] [Abstract][Full Text] [Related]
20. Pantothenate kinase-associated neurodegeneration.
Hundallah K; Al Hakeem A
Neurosciences (Riyadh); 2017 Apr; 22(2):156-157. PubMed ID: 28416789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
